Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Hooker

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|March 4, 2016
Accelerating Monte Carlo power studies through parametric power estimationSebastian Ueckert, Mats O Karlsson, Andrew C Hooker
Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005
Robust population pharmacokinetic experiment designMichael G Dodds, Andrew C Hooker, Paolo Vicini
Journal of Pharmacokinetics and Pharmacodynamics|March 21, 2015
Improved precision of exposure-response relationships by optimal dose-selection. Examples from studies of receptor occupancy using PET and dose finding for neuropathic pain treatmentMatts Kågedal, Mats O Karlsson, Andrew C Hooker
Pharmaceutical Research|March 12, 2010
Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regressionC Steven Ernest, Andrew C Hooker, Mats O Karlsson
Pharmaceutical Research|July 7, 2007
Conditional weighted residuals (CWRES): a model diagnostic for the FOCE methodAndrew C Hooker, Christine E Staatz, Mats O Karlsson
Computer Methods and Programs in Biomedicine|March 23, 2016
PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studiesYasunori Aoki, Monika Sundqvist, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 15, 2013
Simultaneous optimal experimental design for in vitro binding parameter estimationC Steven Ernest, Mats O Karlsson, Andrew C Hooker
British Journal of Clinical Pharmacology|November 20, 2014
Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue modelMatts Kågedal, Katarina Varnäs, Andrew C Hooker, et al.
Journal of Clinical Pharmacology|February 28, 2009
Trial treatment length optimization with an emphasis on disease progression studiesStefanie Hennig, Joakim Nyberg, Andrew C Hooker, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of Pharmacokinetics and Pharmacodynamics|March 4, 2016
Accelerating Monte Carlo power studies through parametric power estimationSebastian Ueckert, Mats O Karlsson, Andrew C Hooker
Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2005
Robust population pharmacokinetic experiment designMichael G Dodds, Andrew C Hooker, Paolo Vicini
Journal of Pharmacokinetics and Pharmacodynamics|March 21, 2015
Improved precision of exposure-response relationships by optimal dose-selection. Examples from studies of receptor occupancy using PET and dose finding for neuropathic pain treatmentMatts Kågedal, Mats O Karlsson, Andrew C Hooker
Pharmaceutical Research|March 12, 2010
Methodological comparison of in vitro binding parameter estimation: sequential vs. simultaneous non-linear regressionC Steven Ernest, Andrew C Hooker, Mats O Karlsson
Pharmaceutical Research|July 7, 2007
Conditional weighted residuals (CWRES): a model diagnostic for the FOCE methodAndrew C Hooker, Christine E Staatz, Mats O Karlsson
Computer Methods and Programs in Biomedicine|March 23, 2016
PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studiesYasunori Aoki, Monika Sundqvist, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 15, 2013
Simultaneous optimal experimental design for in vitro binding parameter estimationC Steven Ernest, Mats O Karlsson, Andrew C Hooker
British Journal of Clinical Pharmacology|November 20, 2014
Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue modelMatts Kågedal, Katarina Varnäs, Andrew C Hooker, et al.
Journal of Clinical Pharmacology|February 28, 2009
Trial treatment length optimization with an emphasis on disease progression studiesStefanie Hennig, Joakim Nyberg, Andrew C Hooker, et al.
Pageof 8